STOCK TITAN

BIOTECH MEDICS INC - BMCS STOCK NEWS

Welcome to our dedicated page for BIOTECH MEDICS news (Ticker: BMCS), a resource for investors and traders seeking the latest updates and insights on BIOTECH MEDICS stock.

BioTech Medics, Inc. (BMCS) is a publicly traded company focusing on the biotech sector located in Los Angeles, California. The firm is transitioning back to its origins in the biotech sector after facing challenges in the digital asset business. BMCS is currently moving towards the calcium, calcium carbonate, and silica marketplaces, with significant digital assets still in play. Recent acquisitions of calcium carbonate assets indicate a shift towards revenue generation and product development in the industry. With plans to elevate to the OTCQB status and reduce common shares, the company aims to capitalize on its opportunities for sustained growth and profitability.

Rhea-AI Summary

BioTech Medics, Inc. (OTC PINK:BMCS) has announced two significant developments. Firstly, the company's CEO, Anthony K. Miller, participated in an interview with The Beast of Wall Street on August 8, 2024, discussing the company's past, present, and future. Secondly, BioTech Medics has launched its official YouTube channel @Biotech Medics.

The YouTube channel will feature various content, including promotional videos and excerpts from the CEO's recent interview. Miller encourages viewers to subscribe and enable notifications to stay updated on the company's business and operations. He expressed hope that these press releases and videos will help investors understand BioTech Medics' business model, which he believes will be a long-running and profitable enterprise.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

BioTech Medics, Inc. (OTC PINK:BMCS) has launched its Commodity Vault website and app, available on Apple App Store and Google Play Store. The platform aims to tokenize real-world commodities like gold, gems, and metals into digital tokens, enabling 24/7 trading in 173 countries. Commodity Vault offers new investment opportunities and capital options for mining and commodity-driven companies.

The app currently features 5 tokenized products: BMCS stock, Calcium, Rhodium, RMC, and Carbon Credits. CEO Anthony K. Miller emphasizes the unique concept of Real-World Asset Tokenization, stating that the company has created the necessary infrastructure and will continue building components for a successful enterprise. Investors are encouraged to download the app and the NovaX wallet to participate in transactions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

BioTech Medics, Inc. (OTC PINK:BMCS) and its subsidiary Commodity Vault have developed the architecture for an RWA Tokenization Trading Platform. This ecosystem includes tokens, commodities, verified blockchains, white papers, apps, wallets, websites, stocks, and strategic partnerships. The company aims to capitalize on the growing Real-World Asset tokenization marketplace, which is projected to reach $10 trillion by the end of the decade according to Boston Consulting Group and 21Shares.

BMCS has launched two new websites: bmcs.company and commodityvault.app. The company reports having over $100M in assets, including $30 million in calcium and the rest in digital assets. With a stock price of $0.03 per share and a float of 38 million shares, management is working to remove the 15c211 restriction to increase tradability.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.45%
Tags
none
Rhea-AI Summary
BioTech Medics, Inc. (OTC PINK:BMCS) announces plans to enhance the company's capital-raising ability and market accessibility. The company aims to increase stock tradability, remove security warnings, and elevate to the OTCQB or greater in 2024. Management is actively pursuing revenue opportunities in the calcium sector, projecting a long-term venture with significant reserves. The company abandoned the name change and digital asset business plan, refocusing on biotech roots and procuring 2 million metric tons of high-quality calcium carbonate for global marketing, with potential for significant profit margins. The business model shift reflects a strategic move to capitalize on substantial opportunities, with a strong focus on enhancing shareholder value.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
BioTech Medics, Inc. has acquired significant organic calcium carbonate assets, valued at over $30 million, and plans to generate revenue by supplying industry with calcium and producing various products. The company projects to earn at least $10 million in the next 15 months, with profit margins of 25-50%. The acquisition provides opportunities for worldwide marketing. The company aims to move to higher tiers on OTCM based on its revenues, assets, and share values.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.1%
Tags
none
Rhea-AI Summary
BioTech Medics, Inc. announces a transition back to the biotech sector and a new business model in the calcium, calcium carbonate, and silica marketplaces. They have achieved OTC Markets Yield status and are retaining their current name. The company plans to utilize their digital assets to enhance their new vision.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

BioTech Medics, Inc. (BMCS) has appointed David Lee Grayson, Jr., a former NFL player, as an ambassador. This partnership aims to leverage Grayson's network to raise $5 million for the company. Grayson also invests in BMCS and possesses extensive experience in finance and sports management. His role involves participation in podcasts and investor forums to enhance company visibility. BMCS is focused on expanding the Sumcoin digital asset, aiming for it to become as liquid as other currencies. The company has filed a Reg. D 506c offering with the SEC to facilitate capital raising.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

BMCS Sumcoin Index Fund has launched a new cryptocurrency investment fund, backed by a $15M initial investment, providing exposure to Sumcoin, an index of the top 100 cryptocurrencies. The fund aims to offer capital appreciation through a single-asset strategy while minimizing risks associated with investing in multiple coins. With approximately $70+ million in managed assets, it is open to qualified U.S. and international accredited investors, requiring a minimum investment of $25,000. The company, formerly known as BioTech Medics, seeks to enhance the liquidity and value of Sumcoin.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.14%
Tags
none
Rhea-AI Summary

BMCS Sumcoin Index Fund, operating as BioTech Medics (OTC PINK: BMCS), has reported over $75 million in assets included in its balance sheet. The company’s investment strategy focuses on Sumcoin (SUM), a digital asset designed to enhance liquidity in the digital marketplace. CEO Anthony K. Miller stated that the current share value does not accurately reflect the company's assets and expressed optimism for future appreciation. BMCS is currently in a soft launch phase while preparing for a broader market engagement.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.7%
Tags
none

FAQ

What is the current stock price of BIOTECH MEDICS (BMCS)?

The current stock price of BIOTECH MEDICS (BMCS) is $0.0158 as of January 10, 2025.

What is the market cap of BIOTECH MEDICS (BMCS)?

The market cap of BIOTECH MEDICS (BMCS) is approximately 3.4M.

What is BioTech Medics, Inc. focused on?

BMCS is transitioning back to the biotech sector, particularly in the calcium, calcium carbonate, and silica marketplaces.

Where is BioTech Medics, Inc. located?

The company is based in Los Angeles, California.

What are some recent achievements of BMCS?

Recent acquisitions of significant calcium carbonate assets indicate a shift towards revenue generation and product development in the industry.

What are the future plans for BioTech Medics, Inc.?

The company aims to elevate to the OTCQB status, reduce common shares, and capitalize on its opportunities for sustained growth and profitability.

How does BMCS plan to enhance its capital position?

BMCS is building the fundamental substructure to raise capital and position itself as a substantial publicly traded firm in the calcium carbonate sector.

What are some key partnerships of BioTech Medics, Inc.?

The company has solid alliances in the calcium sector and is comfortable marketing calcium products to the US marketplace.

What is the long-term vision of BMCS?

The company plans to focus on calcium and silica assets for revenue generation, projecting a significant increase in assets above $70 million dollars.

How does BMCS plan to leverage its calcium carbonate assets?

The company will mine high-quality calcium carbonate assets for marketing to a global marketplace with traditional profit margins.

What distinguishes BioTech Medics, Inc. in the biotech sector?

BMCS's transition back to its biotech roots and strategic acquisitions in the calcium sector position the company for sustained growth and profitability.

How can investors get in touch with BioTech Medics, Inc.?

For investor relations, inquiries, or more information, contact BMCS via email at tonymillertmiller@gmail.com or visit the company's website at www.biotechmedics.co.
BIOTECH MEDICS INC

OTC:BMCS

BMCS Rankings

BMCS Stock Data

3.39M
205.36M
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Southlake